CORC

在结果中检索

CORC

浏览/检索结果: 共8条，第1-8条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：14/0  |  提交时间：2023/11/10
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 37, 期号: 15
作者:  Younes, Anas;  Sehn, Laurie H.;  Johnson, Peter;  Zinzani, Pier Luigi;  Hong, Xiaonan
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05
A Global, Randomized, Placebo-Controlled, Phase 3 Study of Ibrutinib Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (RCHOP) in Patients with Previously Untreated Non-Germinal Center B-Cell-like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) 会议论文
作者:  Duehrsen, Ulrich;  Younes, Anas;  Sehn, Laurie H.;  Johnson, Peter;  Zinzani, Pier Luigi
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab 期刊论文
CLINICAL CANCER RESEARCH, 2013, 卷号: 19, 期号: 9
作者:  Coiffier, Bertrand;  Li, Weimin;  Henitz, Erin D.;  Karkera, Jayaprakash D.;  Favis, Reyna
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study 会议论文
作者:  Coiffier, Bertrand;  Li, Weimin;  Henitz, Erin D.;  Karkera, J. D.;  Favis, Reyna
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial 期刊论文
LANCET ONCOLOGY, 2011, 卷号: 12, 期号: 8
作者:  Coiffier, Bertrand;  Osmanov, Evgenii A.;  Hong, Xiaonan;  Scheliga, Adriana;  Mayer, Jiri
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma 会议论文
作者:  Coiffier, Bertrand;  Osmanov, Evgenii;  Hong, Xiaonan;  Scheliga, Adriana;  Mayer, Jiri
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace